Eli Lilly and Co (LLY)

Add to Watchlists
Create an Alert
Quickflows
241.17 -2.55  -1.05% NYSE Oct 21, 16:00 240.95 -0.22  -0.09% Pre-Market: 08:52 USD
View Full Chart
Price Chart
View All Key Stats

Key Stats

View All LLY News

News

View All Events

Events

Date Type Description
11/12/2021 Dividends 0.85 Normal dividend, declared October 18, 2021 and paid December 10, 2021
10/26/2021 Earnings Results Q3 2021 Earnings Results
10/26/2021 09:00 EST Earnings Calls Q3 2021 Earnings Call
08/12/2021 Dividends 0.85 Normal dividend, declared June 29, 2021 and paid September 10, 2021
08/03/2021 Earnings Results Q2 2021 Earnings Results
08/03/2021 09:00 EST Earnings Calls Q2 2021 Earnings Call
05/13/2021 Dividends 0.85 Normal dividend, declared May 03, 2021 and paid June 10, 2021
05/03/2021 11:00 EST AGM 2020 Annual General Meeting
04/27/2021 Earnings Results Q1 2021 Earnings Results
04/27/2021 09:00 EST Earnings Calls Q1 2021 Earnings Call
View All Performance Charts

Total Returns Comparison

Fundamentals

Income Statement View Statement

Revenue (TTM) 26.73B
Total Expenses (TTM) 19.92B
Net Income (TTM) 6.071B

Balance Sheet View Statement

Total Assets (Quarterly) 47.81B
Total Liabilities (Quarterly) 41.15B
Shareholders Equity (Quarterly) 6.444B

Cash Flow Statement View Statement

Cash from Operations (TTM) 7.095B
Cash from Investing (TTM) -2.754B
Cash from Financing (TTM) -3.712B

Ratings & Reports

Advertisement
Edit

Profile

  • Description: Eli Lilly is a drug firm with a focus on neuroscience, endocrinology, oncology, and immunology. Lilly's key products include Alimta and Verzenio for cancer; Jardiance, Trulicity, Humalog, and Humulin for diabetes; and Taltz and Olumiant for immunology.
  • URL: https://www.lilly.com
  • Investor Relations URL: https://investor.lilly.com/
  • HQ State/Province: Indiana
  • Sector: Healthcare
  • Industry: Drug Manufacturers - General
  • Equity Style: Large Cap/Growth
  • Next Earnings Release: Oct. 26, 2021
  • Last Earnings Release: Aug. 03, 2021
  • Next Ex-Dividend Date: Nov. 12, 2021
  • Last Ex-Dividend Date: Aug. 12, 2021

Analyst Coverage

Consensus Recommendations
Buy Recommendations Upgrade
Outperform Recommendations Upgrade
Hold Recommendations Upgrade
Underperform Recommendations Upgrade
Sell Recommendations Upgrade
Consensus Recommendation Upgrade
Consensus Rating Upgrade
Target Price
Price 241.17
Price Target Upgrade
Price Target Upside (Daily) Upgrade

Top Fund Holders

Symbol Name Weighting
VPMCX Vanguard PRIMECAP Inv 5.77%
VHCOX Vanguard Capital Opportunity Inv 4.70%
VGHCX Vanguard Health Care Inv 4.67%
XLV Health Care Select Sector SPDR® ETF 3.89%
VHT Vanguard Health Care ETF 3.38%
VEIPX Vanguard Equity-Income Inv 2.13%
USMV iShares MSCI USA Min Vol Factor ETF 1.66%
VYM Vanguard High Dividend Yield ETF 1.62%
VIVAX Vanguard Value Index Inv 1.30%
VTV Vanguard Value ETF 1.30%
FCNKX Fidelity® Contrafund® K 1.10%
IWF iShares Russell 1000 Growth ETF 0.72%

Comparables

Edit
BIIB Biogen Inc
JNJ Johnson & Johnson
MRK Merck & Co Inc
PFE Pfizer Inc
ABBV AbbVie Inc

Other Resources

Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.

Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.